Table 3.
The results of network meta‐analysis for regression of left ventricular hypertrophy
| ACEI | −3.72 (−7.52, −0.11) | 0.86 (−3.22, 4.94) | 0.33 (−2.34, 2.98) | ‐1.09 (−4.42, 2.43) |
|---|---|---|---|---|
| 3.72 (0.11, 7.52) | ARB | 4.57 (1.12, 8.07) | 4.07 (0.24, 8.03) | 2.62 (−1.64, 7.07) |
| ‐0.86 (−4.94, 3.22) | ‐4.57 (−8.07, −1.12) | BB | ‐0.53 (−4.65, 3.60) | ‐1.93 (−6.31, 2.66) |
| ‐0.33 (−2.98, 2.34) | ‐4.07 (−8.03, −0.24) | 0.53 (−3.60, 4.65) | CCB | ‐1.42 (−4.86, 2.08) |
| 1.09 (−2.43, 4.42) | ‐2.62 (−7.07, 1.64) | 1.93 (−2.66, 6.31) | 1.42 (−2.08, 4.86) | DIU |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta‐blockers; CCB, calcium channel blocker; DIU, diuretic.